THE RESULT OF INTENSIVE THERAPY OF MULTIPLE ORGAN FAILURE IN BURNED
Keywords:
deep burns, burn shock, multiple organ failure, intensive careAbstract
Multiple organ failure syndrome complicates the course of many diseases and critical conditions and is the maincause of mortality. The course of burn disease is accompanied by multiple organ disorders, however, in severely burned patients, this syndrome is practically not covered in domestic and foreign literature, its pathogenesis, structure, features of clinical and morphological manifestations have not been studied. The structures of MOF were studied in 210 patients (average age 25.5±5.4 years) with deep burns of more than 25% of the body surface and burn shock of I-II-III degree. The introduction of advanced complex intensive infusiontransfusion therapy, the use of organoprotective therapy, as well as correction of the burdened premorbid background, nutritional support facilitates the course of shock, reduces the number of patients with multiple organ failure and mortality in severely burned. Thanks to the application of the principles of intensive therapy during the period of MOF in patients with burn shock, we managed to reduce mortality from 9.6 (in 2010) to 2.8% (in 2022).
References
Heidelbaugh J.J., Kim A.H., Chang R., Walker P.C. Overutilization of proton-pump inhibitors: what the clinician needs to know // Therap. Adv. Gastroenterol. - 2012. - Vol.5. - №4. - P.219- 232.
Iida H., Kato S., Sekino Y. et al. Early effects of oral administration of omeprazole and roxatidine on gastric pH // J. Zhejiang. Univ. Sci. B. - 2012. - Vol.13. - №1. - P.29-34.
Johnson D.A., Oldfield E.C. Reported side effects and complications of long-term proton pump inhibitor use: dissecting the evidence // Clin. Gastroenterol. Hepatol. - 2013. - Vol.11. - №5. - P.458-464.
Khalili H.,Dashti-Khavidaki S., Hossein-Talasaz A.H. et al. Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward // J. Manag. Care Pharm. - 2010. - Vol.16. - №2. - P.114-121.
Kim Y.J., Koh D.H., Park S.W. et al. Upper gastrointestinal bleeding in severely burned patients: a case-control study to assess risk factors, causes and outcome // Hepatogastroenterology. - 2014. - Vol.61. - №136. - P.2256-2259.
Kirkpatrick A.W., Roberts D.J., De Waele J. et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome// Intensive Care Med. – 2013. – Vol. 39(7). – P. 1190-206.
Klebl F.H., Scholmerich J. Therapy insight: Prophylaxis of stress-induced gastrointestinal bleeding in critically ill patients // Nat. Clin. Pract. Gastroenterol. Hepatol. - 2007. - Vol.4. - №10. - P.562-570.
Kollias S., Stampolidis N., Kourakos P., Mantzari E., Koupidis S., Tsaousi S., Dimitrouli A., Atiyeh B., Castana O. Abdominal compartment syndrome (ACS) in a severely burned patient // Ann. Burns Fire Disasters. - 2015. - Vol. 28(1). - P. 5-8.
Lanas A., Carrera-Lasfuentes P., Arguedas Y. et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents or anticoagulants // Clin. Gastroenterol. Hepatol. - 2015. - Vol.13. - №5.P.906-912.
Lin P.C., Chang C.H., Hsu P.I. et al. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis // Crit. Care Med. - 2010. - Vol.38. - №4. - P.1197- 1205.
MacLaren R., Reynolds P.M., Allen R.R. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit // JAMA Intern. Med. - 2014. - Vol.174. - №4. - P.564-574.
